SomaLogic, Inc.

SomaLogic, Inc. (Nasdaq: SLGC) is a Boulder, Colorado-based proteomics company that completed its SPAC merger with CM Life Sciences III Inc. in September 2021, sponsored by CM Life Sciences III Sponsor, LLC, a vehicle affiliated with Casdin Capital and Cormorant Asset Management. Operating in the life sciences and protein biomarker discovery sector, SomaLogic provides large-scale protein measurement services to pharmaceutical, biotechnology, and academic research clients. The company filed an 8-K with the SEC on June 9, 2023, and remained a publicly traded entity on Nasdaq at the time of filing. Visit SpacDesk and sign up for full filings history, sponsor analytics, and post-merger performance data on SLGC.